Evidence map›Paper›PMID 29378845›Full record

ArticleThe Journal of biological chemistry2018

Estrogen receptor α protects pancreatic β-cells from apoptosis by preserving mitochondrial function and suppressing endoplasmic reticulum stress.

Zhenqi Zhou, Vicent Ribas, Prashant Rajbhandari, Brian G Drew, Timothy M Moore, Amy H Fluitt, Britany R Reddish, Kate A Whitney, Senta Georgia, Laurent Vergnes and 12 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Sex as a modifier of genetic risk for type 1 diabetes.Diabetes, obesity & metabolism · 2025
    Review
  8. Article
  9. FOXM1 cooperates with ERα to regulate functional β-cell mass.American journal of physiology. Endocrinology and metabolism · 2025
    Article
  10. Loss of ovarian function prevents exercise-induced activation of hepatic mitophagic flux.American journal of physiology. Endocrinology and metabolism · 2025
    Article
  11. Metabolic Messengers: oestradiol.Nature metabolism · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Role of Estrogen across Multiple Disease Mechanisms.Current issues in molecular biology · 2024
    Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 1 country.

Zhenqi ZhouDepartment of Medicine, Division of Endocrinology, Diabetes and Hypertension, Los Angeles, California 90095.
Vicent RibasDepartment of Medicine, Division of Endocrinology, Diabetes and Hypertension, Los Angeles, California 90095.
Prashant RajbhandariDepartment of Pathology and Laboratory Medicine and the Howard Hughes Research Institute, Los Angeles, California 90095.
Brian G DrewDepartment of Medicine, Division of Endocrinology, Diabetes and Hypertension, Los Angeles, California 90095.
Timothy M MooreDepartment of Medicine, Division of Endocrinology, Diabetes and Hypertension, Los Angeles, California 90095.
Amy H FluittDepartment of Medicine, Division of Endocrinology, Diabetes and Hypertension, Los Angeles, California 90095.
Britany R ReddishDepartment of Medicine, Division of Endocrinology, Diabetes and Hypertension, Los Angeles, California 90095.
Kate A WhitneyDepartment of Medicine, Division of Endocrinology, Diabetes and Hypertension, Los Angeles, California 90095.
Senta GeorgiaDepartment of Medicine, Division of Endocrinology, Diabetes and Hypertension, Los Angeles, California 90095.
Laurent VergnesDepartments of Human Genetics, Los Angeles, California 90095.
Karen ReueDepartments of Human Genetics, Los Angeles, California 90095.
Marc LiesaDepartment of Medicine, Division of Endocrinology, Diabetes and Hypertension, Los Angeles, California 90095.
Orian ShirihaiDepartment of Medicine, Division of Endocrinology, Diabetes and Hypertension, Los Angeles, California 90095.
Alexander M van der BliekBiological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, California 90095.
Nai-Wen ChiDepartment of Medicine, University of California, San Diego, La Jolla, California 92037.
Sushil K MahataDepartment of Medicine, University of California, San Diego, La Jolla, California 92037; Veterans Affairs San Diego Healthcare System, San Diego, California 92161.
Joseph P TianoDepartment of Medicine and Pharmacology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112.
Sylvia C HewittReceptor Biology Section, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709.
Peter TontonozDepartment of Pathology and Laboratory Medicine and the Howard Hughes Research Institute, Los Angeles, California 90095.
Kenneth S KorachReceptor Biology Section, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709.
Franck Mauvais-JarvisDepartment of Medicine and Pharmacology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112.
Andrea L HevenerDepartment of Medicine, Division of Endocrinology, Diabetes and Hypertension, Los Angeles, California 90095; Iris Cantor UCLA Women's Health Research Center, Los Angeles, California 90095. Electronic address: ahevener@mednet.ucla.edu.
Howard Hughes Medical Institute · USTulane University · USUniversity of California, San Diego · USNational Institute of Environmental Health Sciences · USTriangle · USUCLA Health · USUniversity of California, Los Angeles · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Leigh Lamonica · 2012 to 2026
$69.1M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Systems genomics of metabolic syndrome traitsP01HL028481 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PAJUKANTA, PAIVI · 1985 to 2019
$50.2M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrea L Hevener · 2003 to 2026
$40.4M
EXPANSION OF NURSA TRANSCRIPTOMINE ANNOTATIONU24DK097748 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI EVANS, RONALD M, MCKENNA, NEIL · 2012 to 2017
$9.2M
Targeting the estrogen receptor-α to protect functional β-cell mass in womenR01DK074970 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI Franck Mauvais-Jarvis · 2007 to 2026
$6.0M
Mechanisms controlling skeletal muscle mitochondrial function and metabolic healthR01DK109724 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HEVENER, ANDREA L · 2016 to 2020
$2.4M
Mitochondrial regulation of energy efficiencyR01DK099618 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CORKEY, BARBARA E., SHIRIHAI, ORIAN S · 2014 to 2018
$1.8M
Repurposing estrogens to improve pancreatic islet transplantationR01DK107444 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI MAUVAIS-JARVIS, FRANCK · 2016 to 2019
$1.5M
ERalpha and the metabolic syndromeR01DK089109 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HEVENER, ANDREA L · 2011 to 2014
$1.4M
Contributions of mitochondrial fission proteins to mitophagyU01GM109764 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VAN DER BLIEK, ALEXANDER M · 2014 to 2017
$1.1M
The Role of PPARgamma Expression on Insulin ActionK01DK060484 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HEVENER, ANDREA L · 2002 to 2006
$542k
BLRD VA I01 BX003725NCATS NIH HHS UL1 TR000124NHLBI NIH HHS P01 HL028481NIDDK NIH HHS F31 DK108657NIDDK NIH HHS K01 DK060484NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK074970NIDDK NIH HHS R01 DK089109NIDDK NIH HHS R01 DK099618NIDDK NIH HHS R01 DK107444NIDDK NIH HHS R01 DK109724NIDDK NIH HHS U24 DK097748NIGMS NIH HHS U01 GM109764NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Estrogen receptor α (ERα) action plays an important role in pancreatic β-cell function and survival; thus, it is considered a potential therapeutic target for the treatment of type 2 diabetes in women. However, the mechanisms underlying the protective effects of ERα remain unclear. Because ERα regulates mitochondrial metabolism in other cell types, we hypothesized that ERα may act to preserve insulin secretion and promote β-cell survival by regulating mitochondrial-endoplasmic reticulum (EndoRetic) function. We tested this hypothesis using pancreatic islet-specific ERα knockout (PERαKO) mice and Min6 β-cells in culture with Esr1 knockdown (KD). We found that Esr1-KD promoted reactive oxygen species production that associated with reduced fission/fusion dynamics and impaired mitophagy. Electron microscopy showed mitochondrial enlargement and a pro-fusion phenotype. Mitochondrial cristae and endoplasmic reticulum were dilated in Esr1-KD compared with ERα replete Min6 β-cells. Increased expression of

Indexed as

ApoptosisEndoplasmic Reticulum StressMitophagyAnimalsCell SurvivalEstrogen Receptor alphaFemaleInsulinInsulin-Secreting CellsMetalloproteasesMiceMice, KnockoutMitochondriaMitochondrial ProteinsReactive Oxygen SpeciesTranscription Factor CHOPDdit3 protein, mouseEstrogen Receptor alphaInsulinMetalloproteasesMitochondrial ProteinsOMA1 protein, mouseReactive Oxygen SpeciesTranscription Factor CHOPapoptosisendoplasmic reticulum stress (ER stress)estrogen actionestrogen receptorinsulin secretionmitochondrial dynamicsmitochondrial metabolism

Identifiers

PMID29378845
PMCPMC5880140
OpenAlexW2785312775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.